Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Janux Therapeutics Inc (NQ: JANX ) 40.96 +0.66 (+1.64%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,110,881 Open 40.55 Bid (Size) 41.00 (1) Ask (Size) 43.00 (7) Prev. Close 40.30 Today's Range 39.13 - 41.91 52wk Range 5.650 - 65.60 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday May 31, 2024 Via Benzinga The Latest Analyst Ratings For Janux Therapeutics May 30, 2024 Via Benzinga Performance YTD +271.69% +271.69% 1 Month -9.68% -9.68% 3 Month +3.62% +3.62% 6 Month +287.51% +287.51% 1 Year +237.95% +237.95% More News Read More Analyst Ratings For Janux Therapeutics May 13, 2024 Via Benzinga JANX Stock Earnings: Janux Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights May 07, 2024 From Janux Therapeutics Via Business Wire A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts April 16, 2024 Via Benzinga Why Janux Therapeutics Stock Is Crushing It This Week April 12, 2024 Via The Motley Fool Take the Money and Run: 3 Overbought Stocks to Sell ASAP April 17, 2024 Via InvestorPlace These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? April 16, 2024 Via InvestorPlace Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Via Benzinga Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday? April 11, 2024 Via Benzinga Forecasting The Future: 4 Analyst Projections For Janux Therapeutics March 20, 2024 Via Benzinga Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday April 11, 2024 Via Benzinga Topics Stocks Exposures US Equities Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options April 11, 2024 Via Investor's Business Daily Why Janux Therapeutics Stock Soared as the Market Sagged Today April 10, 2024 Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session April 04, 2024 Via Benzinga Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst March 20, 2024 Via Benzinga JANX Stock Earnings: Janux Therapeutics Beats EPS, Beats Revenue for Q4 2023 March 15, 2024 Via InvestorPlace 2 Stocks That Have More Than Tripled This Year: Are They Buys? March 15, 2024 Via The Motley Fool B of A Securities Maintains Buy Rating for Janux Therapeutics: Here's What You Need To Know March 13, 2024 Via Benzinga Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights March 08, 2024 From Janux Therapeutics Via Business Wire Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 12, 2024 Via Benzinga 5 Stocks That More Than Doubled In February March 03, 2024 Via Talk Markets Topics Stocks Exposures US Equities After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? March 02, 2024 Via The Motley Fool Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants February 29, 2024 From Janux Therapeutics Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
